These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
172 related items for PubMed ID: 2107064
21. In-vitro and in-vivo antibacterial activity of CFC-222, a new fluoroquinolone. Kim JH, Choi KH, Kim JW, Lee JH, Choi EC, Kim BK. J Antimicrob Chemother; 1998 Feb; 41(2):223-9. PubMed ID: 9533464 [Abstract] [Full Text] [Related]
22. In vitro and in vivo antibacterial activities of CS-940, a new 6-fluoro-8-difluoromethoxy quinolone. Masuda N, Takahashi Y, Otsuki M, Ibuki E, Miyoshi H, Nishino T. Antimicrob Agents Chemother; 1996 May; 40(5):1201-7. PubMed ID: 8723467 [Abstract] [Full Text] [Related]
23. In vivo activity of ceftriaxone (Ro 13-9904), a new broad-spectrum semisynthetic cephalosporin. Beskid G, Christenson JG, Cleeland R, DeLorenzo W, Trown PW. Antimicrob Agents Chemother; 1981 Aug; 20(2):159-67. PubMed ID: 6269487 [Abstract] [Full Text] [Related]
24. Comparative in vitro activity of RO 23-6240 (fleroxacin), a new 4-quinolone derivative. Machka K, Braveny I. Eur J Clin Microbiol; 1987 Aug; 6(4):482-5. PubMed ID: 3117538 [Abstract] [Full Text] [Related]
28. Cephalosporin 3'-quinolone esters with a dual mode of action. Albrecht HA, Beskid G, Chan KK, Christenson JG, Cleeland R, Deitcher KH, Georgopapadakou NH, Keith DD, Pruess DL, Sepinwall J. J Med Chem; 1990 Jan; 33(1):77-86. PubMed ID: 2153215 [Abstract] [Full Text] [Related]
29. Antibacterial activities and pharmacokinetics of E-4767 and E-5065, two new 8-chlorofluoroquinolones with a 7-azetidin ring substituent. Gargallo-Viola D, Ferrer S, Tudela E, Robert M, Coll R, Roser R, Guinea J. Antimicrob Agents Chemother; 2001 Nov; 45(11):3113-21. PubMed ID: 11600365 [Abstract] [Full Text] [Related]
30. Antibacterial activities of grepafloxacin, ciprofloxacin, ofloxacin and fleroxacin. Barry AL, Fuchs PC. J Chemother; 1997 Feb; 9(1):9-16. PubMed ID: 9106012 [Abstract] [Full Text] [Related]
33. In vitro activity of Ro 23-6240, a new difluoroquinolone derivative, compared with that of other antimicrobial agents. Manek N, Andrews JM, Wise R. Antimicrob Agents Chemother; 1986 Aug; 30(2):330-2. PubMed ID: 3094444 [Abstract] [Full Text] [Related]
35. [Dual cephalosporins--a return of fixed combinations of antibiotics?]. Krcméry V. Cas Lek Cesk; 1990 Jul 20; 129(29):914-6. PubMed ID: 2393897 [Abstract] [Full Text] [Related]
36. Effect of RO 23-9424, cefotaxime and fleroxacin on functions of human polymorphonuclear cells and cytokine production by human monocytes. Matera G, Berlinghieri MC, Foti F, Barreca GS, Focà A. J Antimicrob Chemother; 1996 Nov 20; 38(5):799-807. PubMed ID: 8961049 [Abstract] [Full Text] [Related]
37. In vitro activity of Ro 13-9904, a new beta-lactamase-stable cephalosporin. Verbist L, Verhaegen J. Antimicrob Agents Chemother; 1981 Feb 20; 19(2):222-5. PubMed ID: 6289726 [Abstract] [Full Text] [Related]
38. Comparative in-vitro activity and mode of action of ceftriaxone (Ro 13-9904), a new highly potent cephalosporin. Hall MJ, Westmacott D, Wong-Kai-In P. J Antimicrob Chemother; 1981 Sep 20; 8(3):193-203. PubMed ID: 6270051 [No Abstract] [Full Text] [Related]
39. In vitro activity of fleroxacin against aerobic gram-positive bacteria including Corynebacterium jeikeium. Hohl P, Felber AM. Chemotherapy; 1990 Sep 20; 36(6):403-6. PubMed ID: 2127242 [Abstract] [Full Text] [Related]